Lipid Disorders in CKD: nature and underlying molecular mechanisms 3.1. Dyslipidemia of CKD and ESRD 3.1.1. Alterations in triglyceride and triglyceride-rich lipoprotein metabolism 3.1.2. Alterations in cholesterol and low density lipoprotein metabolism
نویسندگان
چکیده
1. Abstract 2. Introduction 3. Lipid Disorders in CKD: nature and underlying molecular mechanisms 3.1. Dyslipidemia of CKD and ESRD 3.1.1. Alterations in triglyceride and triglyceride-rich lipoprotein metabolism 3.1.2. Alterations in cholesterol and low density lipoprotein metabolism 3.1.3. Alterations in high density lipoprotein metabolism 4. Summary and perspective 5. Acknowledgements 6. References [Frontiers In Bioscience, Landmark, 23, 146-161, January 1, 2018]
منابع مشابه
Serum Lipid Profile Alterations in Acute Leukemia Before and After Chemotherapy
Background: Serum lipids abnormalities have been observed in various forms of cancers including acute leukemia. Investigators report decreased total cholesterol and HDL, and elevated triglyceride in leukemic patients. Limited studies had been performed to discover the correlation between abnormal lipids profile and disease activity in leukemic patients in Iran. This study was done to evaluate t...
متن کاملManaging Dyslipidemia in Chronic Kidney Disease
The incidence of chronic kidney disease (CKD) in the U.S. continues to increase, and now over 10% of the U.S. population has some form of CKD. Although some patients with CKD will ultimately develop renal failure, most patients with CKD will die of cardiovascular disease before dialysis becomes necessary. Patients with CKD have major proatherogenic lipid abnormalities that are treatable with re...
متن کاملEffects of Dietary Chitosan on Serum Lipid and Lipoprotein Concentration in Rats
Because the ingestion of some types of dietary fibers has been shown to influence on the lipid and lipoprotein levels, it is possible that chitosan influences on lipid metabolism. In the present study, the effects of chitosan on the serum, liver lipid and lipoprotein concentrations in rat were investigated. Serum lipid level in the treatment groups were decreased compared to that of the control...
متن کاملنقش ژن SHIP2 در لیپوژنز القایی توسط اولئات
Introduction: Dyslipidemia is one of the key risk factors for cardiovascular disease in type 2 diabetes (T2D). The dyslipidemia is characterized by increased plasma concentration of triglycerides (TG), reduced concentration of high density lipoprotein cholesterol (HDL-C) and an increased concentration of small dense low density lipoprotein (LDL) cholesterol. Evidence from bo...
متن کاملAlterations of Lipid Metabolism in Chronic Nephropathies: Mechanisms, Diagnosis and Treatment
Nephropathic subjects show an increased tendency to develop cardiovascular diseases, mainly as the consequence of several risk factors including increased oxidative stress, inflammation, physical inactivity, anemia, vascular calcification, and endothelial dysfunction. The alterations in lipid metabolism represent a relatively lesser important cause of genesis and progression of atherosclerosis....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017